Header Logo

Connection

FERDINANDOS SKOULIDIS to United States Food and Drug Administration

Back to Details
This is a "connection" page, showing publications FERDINANDOS SKOULIDIS has written about United States Food and Drug Administration.
FERDINANDOS SKOULIDIS
Connection Strength
0.123
United States Food and Drug Administration
  1. Personalized Medicine Tackles Clinical Resistance: Alectinib in ALK-Positive Non-Small Cell Lung Cancer Progressing on First-Generation ALK Inhibitor. Clin Cancer Res. 2016 Nov 01; 22(21):5177-5182.
    View in: PubMed
    Score: 0.123
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.